Literature DB >> 11884659

Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition.

Alfredo A L d'Alfonso1, André Aleman, Roy P C Kessels, Eugène A Schouten, Albert Postma, Jeroen A van Der Linden, Wiepke Cahn, Yvonne Greene, Edward H F de Haan, René S Kahn.   

Abstract

The effects of transcranial magnetic stimulation (TMS) on hallucination severity and neurocognition were studied in 9 medication-resistant hallucinating patients. A statistically significant improvement was observed on a hallucination scale after 10 days of TMS at the left auditory cortex.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11884659     DOI： 10.1176/jnp.14.1.77

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  11 in total

1.  Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry.

Authors:  John P O'Reardon; Andrew D Peshek; Rocio Romero; Pilar Cristancho
Journal:  Psychiatry (Edgmont)       Date:  2006-01

2.  Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.

Authors:  Yi Jin; Steven G Potkin; Aaron S Kemp; Steven T Huerta; Gustavo Alva; Trung Minh Thai; Danilo Carreon; William E Bunney
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 3.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

Review 4.  Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?

Authors:  Asli Demirtas-Tatlidede; Andrew M Vahabzadeh-Hagh; Alvaro Pascual-Leone
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

5.  Transcranial magnetic stimulation for schizophrenia.

Authors:  Nadine Dougall; Andrew McIntosh; Klaus P Ebmeier
Journal:  Cochrane Database Syst Rev       Date:  2006

Review 6.  Safety and tolerability of repetitive transcranial magnetic stimulation in patients with pathologic positive sensory phenomena: a review of literature.

Authors:  Paul A Muller; Alvaro Pascual-Leone; Alexander Rotenberg
Journal:  Brain Stimul       Date:  2011-06-14       Impact factor: 8.955

Review 7.  Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes.

Authors:  Alkomiet Hasan; Wolfgang Strube; Ulrich Palm; Thomas Wobrock
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

8.  Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study.

Authors:  Monika Klirova; Jiri Horacek; Tomas Novak; Jan Cermak; Filip Spaniel; Lucie Skrdlantova; Pavel Mohr; Cyril Höschl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-15       Impact factor: 5.270

9.  Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.

Authors:  Catarina Freitas; Felipe Fregni; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2009-01-11       Impact factor: 4.939

10.  High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With Schizophrenia.

Authors:  Sonia Dollfus; Nemat Jaafari; Olivier Guillin; Benoit Trojak; Marion Plaze; Ghassen Saba; Cécilia Nauczyciel; Aurélie Montagne Larmurier; Nathalie Chastan; Vincent Meille; Marie-Odile Krebs; Samar S Ayache; Jean Pascal Lefaucheur; Annick Razafimandimby; Elise Leroux; Rémy Morello; Jean Marie Batail; Perrine Brazo; Nicolas Lafay; Issa Wassouf; Ghina Harika-Germaneau; Remy Guillevin; Carole Guillevin; Emmanuel Gerardin; Maud Rotharmel; Benoit Crépon; Raphael Gaillard; Christophe Delmas; Gael Fouldrin; Guillaume Laurent; Clément Nathou; Olivier Etard
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.